arrow-down arrow-left arrow-right check clock edit filter phone question-mark search submit-arrow

What does myTomorrows do?

 

We facilitate early access to medicines in development for physicians and their patients that have run out of treatment options.

 

Many physicians and their patients with unmet medical needs, struggle to gain access to medicines in development. Access to medicines in development outside of clinical trials is complex, lengthy and burdensome.

What does myTomorrows do?

 

We facilitate early access to medicines in development for physicians and their patients that have run out of treatment options.

 

Many physicians and their patients with unmet medical needs, struggle to gain access to medicines in development. Access to medicines in development outside of clinical trials is complex, lengthy and burdensome.

How it works

 

If you have a patient suffering from a life threatening or debilitating disease for whom adequate treatment options or relevant clinical trials are not available, you can follow these steps:

 

Contact our medical team to learn about possible treatment options for your patient.

Our medical team will answer any questions you have about a specific treatment, providing you with clinical data and actionable information.

You decide whether pursuing this treatment is a suitable next step.

When the treatment is prescribed we can assist with a range of regulatory, reimbursement, documentation, logistics and pharmacovigilance services. Our service is free of charge.

 

 

 

Our services are free of charge. Reimbursement of the medicine differs per country. At myTomorrows we believe that everyone should have access to all suitable treatment options.

 

We take our responsibility very seriously and adhere to the highest pharmaceutical and ethical standards, and strive to be fully transparent in how we operate.

 

Physician and patient in control

 

myTomorrows does not provide any form of diagnostic services. We do not provide advice or recommendations on treatment options. Physician and patient are always the ones making the final decision.

 

It is up to the physician and the patient to assess if the expected benefit from the investigational drug outweighs the associated risks.

Our services include the following

 

• Support the search for and access to suitable treatment solutions

 

• Facilitate regulatory approval for Early Access treatments (if required)

 

• Provide transparency and support on different reimbursement pathways

 

• Handle documentation and coordinate logistics with pharmacists and hospitals

 

• Collect safety data through our pharmacovigilance system

 

 

"At myTomorrows, we believe that everyone should have access to all suitable treatment options, whenever available, wherever they exist. ”

"At myTomorrows, we believe that everyone should have access to all suitable treatment options, whenever available, wherever they exist. ”

 

Ronald Brus MD,  Founder  & CEO of myTomorrows